| Application no. and date | 17735004.8 (espacenet) (Federated) (European Patent Register), 20170609 | | Patent/reg. no. and date | DK/EP 3307267, 20190410 | | Publication date | 20180418 | | Priority no. and date | WO PCT/EP2016/063368, 20160610 | | EP pub. no. and date |
EP 3307267 20180418 | | Effective date | | | Applicant/owner | Oryzon Genomics, S.A., Carrera de San Jérónimo 15
2nd floor
28014 Madrid, ES | | Applicant ref. no. | P68783DK01 | | Inventor | MAES, Tamara, Oryzon Genomics S.A.
Sant Ferran 74
08940 Cornella De Llobregat, ES,
MASCARO CRUSAT, Cristina, Oryzon Genomics S.A.
Sant Ferran 74
08940 Cornella De Llobregat, ES,
ROTLLANT POZO, David, Oryzon Genomics S.A.
Sant Ferran 74
08940 Cornella De Llobregat, ES | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/42 (2006.01) | | Title | BEHANDLING AF MULTIPEL SKLEROSE | | Int. application no. | EP2017064206 | | Int. publication no. | WO2017212061 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
